Individuals who have, or are at risk for, various genetic disorders face many challenges concerning disclosures of genetic information in dating situations. We conducted a qualitative interview study of 64 individuals confronting Huntington's disease, breast cancer, or Alpha‐1 antitrypsin deficiency, examining what issues these individuals encountered, and how they viewed and addressed these—including issues of understandings, privacy, and disclosures of genetic information to various groups (e.g., family members). Incidental to the primary research questions addressed, participants also often described a series of dilemmas in dating situations that they and/or family members, friends, and fellow patients faced of whether to date, and if so...
Individuals with a BRCA1 or BRCA2 pathogenic variant have an increased risk of developing breast, ov...
Background: Access to genetic cancer risk information can be highly dependent on whether familial ri...
It has been over 20 years since the inception of predictive testing for Huntington disease (HD), yet...
Individuals with genetic disease face unique challenges related to navigating dating relationships. ...
Objective: This study aims to assess information needs and information sources and seeks to illustra...
Title from PDF of title page (University of Missouri--Columbia, viewed on August 30, 2012).The entir...
Patterns of disclosure of Huntington disease risk and genetic test results among family members are ...
Increased insight into the information needs of people about cancer genetic predisposition could all...
Huntington’s disease (HD) is an autosomal dominant progressive neurodegenerative condition which aff...
This qualitative interview study explored the way in which information about predictive BRCA1/2 test...
Technological advances have made possible genomic and genetic testing for a variety of diseases, war...
Purpose: Genetic counseling may help counselees understand their genetic risk of developing breast/o...
Purpose: Genetic counseling may help counselees understand their genetic risk of developing breast/o...
Purpose: To explore many questions raised by genetics concerning personal identities that have not b...
Advances in genetic and genomic research mean that the identification of a genetic condition or a ge...
Individuals with a BRCA1 or BRCA2 pathogenic variant have an increased risk of developing breast, ov...
Background: Access to genetic cancer risk information can be highly dependent on whether familial ri...
It has been over 20 years since the inception of predictive testing for Huntington disease (HD), yet...
Individuals with genetic disease face unique challenges related to navigating dating relationships. ...
Objective: This study aims to assess information needs and information sources and seeks to illustra...
Title from PDF of title page (University of Missouri--Columbia, viewed on August 30, 2012).The entir...
Patterns of disclosure of Huntington disease risk and genetic test results among family members are ...
Increased insight into the information needs of people about cancer genetic predisposition could all...
Huntington’s disease (HD) is an autosomal dominant progressive neurodegenerative condition which aff...
This qualitative interview study explored the way in which information about predictive BRCA1/2 test...
Technological advances have made possible genomic and genetic testing for a variety of diseases, war...
Purpose: Genetic counseling may help counselees understand their genetic risk of developing breast/o...
Purpose: Genetic counseling may help counselees understand their genetic risk of developing breast/o...
Purpose: To explore many questions raised by genetics concerning personal identities that have not b...
Advances in genetic and genomic research mean that the identification of a genetic condition or a ge...
Individuals with a BRCA1 or BRCA2 pathogenic variant have an increased risk of developing breast, ov...
Background: Access to genetic cancer risk information can be highly dependent on whether familial ri...
It has been over 20 years since the inception of predictive testing for Huntington disease (HD), yet...